Schizophrenia Trial, Recruiting (NCT05962216)

Schizophrenia Trial, Recruiting NCT05962216 Sponsor: Dr. Albert Kar-Kin Chung Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT05962216 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged between 18 and 65 years old at the time of joining the trial
People who are able to read and communicate in English and/or Chinese
People who are able to give informed consent (meaning they can understand and agree to participate)
People who have been diagnosed with a psychotic disorder or certain mood-related disorders, as classified under recognised medical diagnostic systems (DSM-5 or ICD-10) (confirm with trial site for specific diagnoses)
People who have been taking the medication brexpiprazole as part of their treatment for less than 4 weeks at the time of joining

Who may not be able to join:

People under 18 years of age
People who are unable to read or communicate in English or Chinese
People who are unable to give informed consent
People who have been diagnosed with an intellectual disability (as defined by DSM-5 or ICD-10 classifications F70–73)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 2255 4486

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05962216

Sponsor: Dr. Albert Kar-Kin Chung

Phase: Not Applicable

Status: Recruiting

Condition: Schizophrenia

Trial contact: 2255 4486

More information: https://clinicaltrials.gov/study/NCT05962216

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged between 18 and 65 years old at the time of joining the trial
People who are able to read and communicate in English and/or Chinese
People who are able to give informed consent (meaning they can understand and agree to participate)
People who have been diagnosed with a psychotic disorder or certain mood-related disorders, as classified under recognised medical diagnostic systems (DSM-5 or ICD-10) (confirm with trial site for specific diagnoses)
People who have been taking the medication brexpiprazole as part of their treatment for less than 4 weeks at the time of joining

Who may not be able to join:

People under 18 years of age
People who are unable to read or communicate in English or Chinese
People who are unable to give informed consent
People who have been diagnosed with an intellectual disability (as defined by DSM-5 or ICD-10 classifications F70–73)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Dr. Albert Kar-Kin Chung

Registry

ClinicalTrials.gov

Start date

1 July 2023

Est. completion

31 December 2026

Where this trial is recruiting

Hong Kong

Primary endpoints

Change in Brief Psychiatric Rating Scale-24 in 6 months; Change in Clinical Global Impression in 6 months; Change in Beck Anxiety Inventory in 6 months; Change in Beck Depression Inventory in 6 months; Change in Digital Symbol Substitution Test in 6 months; Change in World Health Organization Disability Assessment Schedule 2.0 in 6 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov